For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP490

3700

Dr.Nisha R Pillai
Membership No Author Name Email Mobile
3700 Dr.Nisha R Pillai nisharamp@hotmail.com 7204681090
Medical Retina

Morphological Evolution of SHRM After Anti-VEGF in Neovascular AMD & its Impact on Visual Function

Purpose: To evaluate SHRM evolution after anti-VEGF in nAMD and its visual associations. Methods: 30 eyes were assessed at baseline and monthly for 3 months. SHRM morphology, fluid, BCVA, MNREAD, Amsler and D15 were analysed using repeated-measures tests and mixed-effects regression. Results: Height decreased from 168.7±101.9 to 85.7±98.9µm (49.2%; p<0.001), width from 1825±1607 to 1141±1300µm (37.5%; p<0.001), and BCVA improved from 0.517±0.361 to 0.375±0.310 logMAR (p=0.0006). Fibrotic SHRM (p=0.019), RPE-like reflectivity (p=0.025), well-defined borders (p=0.050) and residual fluid (p=0.028) indicated poorer BCVA. Each 100µm increase in height predicted 0.075-logMAR poorer BCVA (p=0.024). Retinal subsidence followed SHRM resolution in 70%. Greater height and width reduced MNREAD speed (β=−15.73/100µm, p=0.049; β=−14.58/1000µm, p=0.017); Conclusion: Anti-VEGF induces SHRM remodelling; greater height/adverse phenotypes as mentioned above indicate poorer outcomes.

Membership No Author Name Email Mobile
2146 Dr.Divyansh Kailash Chandra divyansh.mishra@gmail.com 8977405171